Publication | Closed Access
Ocular Manifestations of 13-15 Trisomy
24
Citations
30
References
1965
Year
Ocular DiseaseGeneticsMolecular GeneticsClinical GeneticsMendelian DisorderTrisomy SyndromesCraniofacial DevelopmentPublic HealthNeurogeneticsMonogenic DisordersEdwards SyndromeOphthalmologyHistopathologySystematic CountingOcular PathologyMosaicismDevelopmental AnomalyDevelopmental BiologyGenetic DisorderOcular ManifestationsPediatric OphthalmologyMedicineChromosome 9
<h3>Introduction</h3> Severe congenital ocular anomalies including microphthalmos, anophthalmos, and retinal dysplasia<sup>13,23,30-35,45</sup>have long been known to have association with other developmental abnormalities. The clinical pattern of what was possibly 13-15 trisomy was first described by Thomas Bartholin in 1657<sup>35,36</sup>as a "monster without eyes." There are many cases which may be presumed to have represented this syndrome before 1960<sup>21</sup>when Patau et al established the chromosomal basis for it. Following the work of Lejeune et al in 1959,<sup>37</sup>the systematic counting of human chromosomes led to the establishment of three specific autosomal trisomy syndromes with clinical-cytogenetic correlation: 13-15 (Denver<sup>38</sup>system of nomenclature), also referred to as D,<sup>39</sup>or D<sub>1</sub>,<sup>7</sup>or Patau's syndrome; 17-18, or E trisomy, or Edwards syndrome; and 21 or G trisomy (mongolism or Down's syndrome). These trisomy syndromes are recognized clinically by a characteristic array of congenital deformities in
| Year | Citations | |
|---|---|---|
Page 1
Page 1